AMPE — Ampio Pharmaceuticals Balance Sheet
0.000.00%
- $0.12m
- -$3.96m
Annual balance sheet for Ampio Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 6.53 | 17.3 | 33.9 | 12.7 | 4.09 |
Net Total Receivables | — | 0.185 | 0.016 | — | 0.92 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 8.25 | 18.5 | 35.6 | 13.3 | 5.74 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 5.75 | 4.38 | 3.19 | 0.259 | 0 |
Total Assets | 14 | 22.9 | 38.8 | 13.6 | 5.74 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Current Liabilities | 4.28 | 1.83 | 5.12 | 1.19 | 2.38 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 7.56 | 5.37 | 11.5 | 1.8 | 2.38 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 6.44 | 17.5 | 27.3 | 11.8 | 3.36 |
Total Liabilities & Shareholders' Equity | 14 | 22.9 | 38.8 | 13.6 | 5.74 |
Total Common Shares Outstanding |